INSIGHTS &
INDUSTRY NEWS

What healthcare owners can expect during M&A due diligence: when it starts, what buyers review, the quality of earnings process, and how to keep a deal on track.

What healthcare owners should understand before signing a letter of intent: exclusivity, deal structure, re-trade risk, and certainty to close.

Thinking of selling your home health, hospice, or home care agency in 2026? How the CMS moratorium, 36-month rule, and fraud crackdown affect your sale.

How behavioral health business owners can compare offers from buyers, looking beyond the multiple to the cash, structure, and certainty behind each one.

Not every healthcare transaction calls for the same advisor. Learn the difference between a business broker, M&A advisor, and investment banker before deciding who should represent your business.

Home care agency owners have more access to deal data than ever — published multiples, transaction announcements, AI-generated market summaries. But information isn't leverage. The gap between what a buyer offers when they're alone at the table and what they'll pay under competition isn't small. It's the difference between an adequate outcome and a top-of-market one.

A buyer reached out. They know your market, they move fast, and they mention that going direct saves everyone the hassle of a process. It sounds reasonable. It isn't. In two behavioral health transactions — one that went from $7.5M to $15M, another from $37M to $52M — the seller's preferred buyer paid significantly more simply because they knew others were at the table. Same buyer. Same company. Same diligence. The only difference was competition.

Not ready to sell your home care or hospice agency? An M&A advisory firm can still help with valuation guidance, exit planning, and market insights.